Shannon R Reese1, Nancy A Wilson1, Yabing Huang2, Lucille Ptak1, Kenna R Degner1, Ding Xiang3, Robert R Redfield4, Weixiong Zhong5, Sarah E Panzer1. 1. Division of Nephrology, Department of Medicine, University of Wisconsin, Madison, WI. 2. Department of Pathology, Renmin Hospital of Wuhan University, Wuchang District, Wuhan, China. 3. Department of Organ Transplantation, Xiangya Hospital, Central South University, Changsha, Hunan, China. 4. Division of Transplant Surgery, Department of Surgery, University of Wisconsin, Madison, WI. 5. Department of Pathology, University of Wisconsin, Madison, WI.
Abstract
BACKGROUND: Transplant glomerulopathy (TG) is a pathological feature of chronic active antibody-mediated rejection (cAMR) and is associated with renal allograft failure. The specific role of B cells in the pathogenesis of TG is unclear. METHODS: We used a minor mismatched rat kidney transplant model with B cell-deficient recipients, generated by clustered regularly interspaced short palindromic repeats/Cas9 technology, to investigate the impact of B-cell depletion on the pathogenesis of TG. We hypothesized that B-cell deficiency would prevent TG in the rat kidney transplant model of cAMR. Treatment groups included syngeneic, allogeneic, sensitized allogeneic, and B cell-deficient allogeneic transplant recipients. RESULTS: B cell-deficient recipients demonstrated reduced TG lesions, decreased microvascular inflammation, reduced allograft infiltrating macrophages, and reduced interferon gamma transcripts within the allograft. Allograft transcript levels of interferon gamma, monocyte chemoattractant protein-1, and interleukin-1β correlated with numbers of intragraft macrophages. B cell-deficient recipients lacked circulating donor-specific antibodies and had an increased splenic regulatory T-cell population. CONCLUSIONS: In this model of cAMR, B-cell depletion attenuated the development of TG with effects on T cell and innate immunity.
BACKGROUND: Transplant glomerulopathy (TG) is a pathological feature of chronic active antibody-mediated rejection (cAMR) and is associated with renal allograft failure. The specific role of B cells in the pathogenesis of TG is unclear. METHODS: We used a minor mismatched rat kidney transplant model with B cell-deficient recipients, generated by clustered regularly interspaced short palindromic repeats/Cas9 technology, to investigate the impact of B-cell depletion on the pathogenesis of TG. We hypothesized that B-cell deficiency would prevent TG in the rat kidney transplant model of cAMR. Treatment groups included syngeneic, allogeneic, sensitized allogeneic, and B cell-deficient allogeneic transplant recipients. RESULTS: B cell-deficient recipients demonstrated reduced TG lesions, decreased microvascular inflammation, reduced allograft infiltrating macrophages, and reduced interferon gamma transcripts within the allograft. Allograft transcript levels of interferon gamma, monocyte chemoattractant protein-1, and interleukin-1β correlated with numbers of intragraft macrophages. B cell-deficient recipients lacked circulating donor-specific antibodies and had an increased splenic regulatory T-cell population. CONCLUSIONS: In this model of cAMR, B-cell depletion attenuated the development of TG with effects on T cell and innate immunity.
Authors: Jan Hinrich Bräsen; Abedalrazag Khalifa; Jessica Schmitz; Wei Dai; Gunilla Einecke; Anke Schwarz; Michael Hallensleben; Bernhard M W Schmidt; Hans H Kreipe; Hermann Haller; Sibylle von Vietinghoff Journal: Kidney Int Date: 2017-03-27 Impact factor: 10.612
Authors: Victoria Gorbacheva; Ran Fan; Ashley Beavers; Robert L Fairchild; William M Baldwin; Anna Valujskikh Journal: J Am Soc Nephrol Date: 2019-10-09 Impact factor: 10.121
Authors: Sarah E Panzer; Nancy A Wilson; Bret M Verhoven; Ding Xiang; C Dustin Rubinstein; Robert R Redfield; Weixiong Zhong; Shannon R Reese Journal: Transplantation Date: 2018-03 Impact factor: 4.939
Authors: Vikram Pattanayak; Steven Lin; John P Guilinger; Enbo Ma; Jennifer A Doudna; David R Liu Journal: Nat Biotechnol Date: 2013-08-11 Impact factor: 54.908
Authors: Xingqiang Lai; Xin Zheng; James M Mathew; Lorenzo Gallon; Joseph R Leventhal; Zheng Jenny Zhang Journal: Front Immunol Date: 2021-05-20 Impact factor: 7.561